ESC 365
ESC 365
Sign in
Menu
Menu
Back
Tafamidis for transthyretin amyloid cardiomyopathy: the solution or just the beginning of the end?
European Heart Journal
18 January 2019
Organised by:
Read full article
ESC Journals
CARDIOVASCULAR PHARMACOLOGY
VALVULAR, MYOCARDIAL, PERICARDIAL, PULMONARY, CONGENITAL HEART DISEASE
Myocardial Disease
Pharmacology and Pharmacotherapy
Abstract
Abstract
Contributors
Rodney H Falk
Author